Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Wei's Huoxue Tongluo Recipe is a Traditional Chinese Medicine (TCM) herbal formula primarily developed for the treatment of diabetic peripheral neuropathy (DPN). The recipe is based on the TCM principles of tonifying Qi, activating blood circulation, and dredging the collaterals to address the underlying pathology of 'Qi deficiency and blood stasis' common in chronic diabetic complications. It typically comprises a complex mixture of botanical extracts, including Astragalus membranaceus (Huangqi), Angelica sinensis (Danggui), Ligusticum chuanxiong (Chuanxiong), and Pheretima (Dilong). Clinical research suggests that the formula improves nerve conduction velocity, alleviates symptoms such as numbness and pain, and may exert neuroprotective effects by reducing oxidative stress and improving microcirculation in the peripheral nerves.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Wei's Huoxue Tongluo Recipe.